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Abstract
Background: To determine the relationship between central blood pressure (CBP) indices and mild cognitive
impairment (MCI) in adults over the age of 50.
Methods: A cross-sectional study conducted using a non-invasive SphygmoCor XCEL device. CBP indices and
brachial blood pressure were measured in 50 inpatients and outpatients. MCI was assessed using the Montreal
Cognitive Assessment (MoCA) instrument and by the European Consortium Criteria (ECC).
Results: Seventy-six percent of subjects had hypertension, and 52% were diagnosed as having MCI using the ECC.
No significant association was found between any of the measured blood pressure variables and global cognition.
A significant relationship was observed between augmentation index (AI) and abnormal clock-drawing (p = 0.04)
and language (p = 0.02), and between pulse pressure amplification (PPA) and language (p = 0.03).
Conclusion: CBP indices like AI and PPA, which are markers of vascular stiffness, are associated with poor executive
function and language cognitive domain deficits.
Keywords: Blood pressure, Augmentation pressure, Augmentation index, Arterial stiffness, Elderly, Cognitive
impairment
Background
High blood pressure may exert negative effects on the
brain and contribute to cognitive decline. Hypertension
is seen in 7% of adults aged 18–39 years, 33% of adults
aged 40–59 years and 55% of Medicare beneficiaries [1, 2].
A number of cohort and population studies have shown
an association between hypertension and cognitive impair-
ment/dementia and these studies point out that hyperten-
sion seen in early stages of life can cause cognitive
impairment or dementia [3–5]. Blood pressure variability
as measured by 24-h non-invasive BP monitoring has
been associated with cognitive decline [6]. There is also
evidence that lowering blood pressure in middle-age can
prevent dementia in later life and hypertension is one of
the preventable causes of cognitive decline [7, 8].
Conversely, evidence from large randomized control trials
demonstrated an inconsistent relationship between anti-
hypertensives and cognitive decline [9].
Although blood pressure is typically measured per-
ipherally over the brachial artery, central blood pressure
(CBP) measurements, including aortic blood pressure,
have shown stronger associations with end-organ damage
and may be of greater clinical use. CBP can be measured
non-invasively using validated cuff- based techniques.
Recent studies indicate that the interaction of vascular
stiffness and wave dynamics in the large arteries is an
important mediator of blood pressure elevation with
aging. Pressure waves travelling from the left ventricle to
the aorta and subsequently to the peripheral arteries are
reflected at the arterial junction, resulting in wave retro-
pulsion, which augments pressure in the aortic root. A
recent, prospective, observational study showed a temporal
relationship between vascular stiffness, blood pressure
elevation and progression to hypertension [10].
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Arterial stiffness of the large vessels influences the
pumping of blood from the heart and is an independent
predictor of future cardiovascular events beyond blood
pressure alone. Arterial stiffness measures both structural
(arterial media) and dynamic arterial components (tone of
the smooth muscle in the arterial media). Different blood
pressure indices are used to measure arterial stiffness
(carotid-femoral pulse wave velocity (cfPWV)) and its
associated hemodynamic sequelae with wave reflections
(Pulse Pressure Amplification(PPA) and Augmentation
Index(AI)). These blood pressure indices improve
incremental cardiovascular risk stratification and pre-
diction of future CV outcomes [11]. cfPWV is the com-
mon measure of arterial stiffness (meters/second). AI is
an alternate parameter, representing a ratio measuring
the relationship of forward and backward travelling
waves in the central aorta. PPA reflects the magnitude
of blood pressure augmentation between the central
and peripheral arteries [12].
The association of CBP indices and cognitive decline
has not been widely studied. Therefore, the objective of
this study was to determine the relationship between
central blood pressure (CBP) indices and the cognitive
function of adults over the age of 50 years. This study
may give further insights into the association between
blood pressure and cognitive deterioration.
Methods
In this cross-sectional study, using a non-invasive
SphygmoCor XCEL device (AtCor Medical), CBP indices
(blood pressure, augmentation pressure, augmentation
index, pulse pressure amplification, and pulse wave
velocity) and traditional brachial blood pressure (BBP)
were measured in 50 inpatients and outpatients at the
University of Alberta Hospital and Kaye Edmonton
Clinic. Non-English speaking subjects and those with a
history of dementia, blindness, depression, anxiety,
mental illness, substance abuse and chronic pain were
excluded. Subjects were also excluded when they were
medically unstable or terminally ill, under isolation
precautions or unable to give informed consent. Data
on demographic variables and vascular risk factors in-
cluding hypertension, diabetes and hyperlipidemia was
obtained. Information on history of transient ischemic
attacks (TIA’s), strokes and anti-hypertensive medica-
tions was also obtained.
BP measurements
Blood pressure measurements were obtained after patients
had been resting in a supine position for at least 10 min.
Both brachial and central BP indices were measured at the
beginning and again at the end of the assessment, with
each brachial BP measurement resulting from the average
of two back-to-back readings. Central BP indices were
generated non-invasively from a brachial artery waveform
using the generalized transfer function of the Sphygmocor
XCEL software. Pulse wave velocity was calculated using
the same device, by measurement of the distance and
pulse transit time between the carotid and femoral arteries
(with waveforms captured through carotid applanation
tonometry and a femoral BP cuff, respectively).
Cognitive tests
Cognitive testing was done using MoCA [13] and European
Consortium Criteria (ECC) [14]. MoCA measures seven
cognitive domains including executive function and
abstraction. MoCA has excellent test-retest reliability,
and the internal consistency on the items in MoCA is
0.83. A MoCA score of 26 or less was considered to
signify mild cognitive impairment (MCI). Participants
were classified as having MCI using the following defini-
tions operationalized for this study. A MCI diagnosis was
based on the screening test MoCA (<26 points)(normal or
abnormal) as well as using the European Consortium
Criteria(present or absent). MCI was diagnosed according
to the European Consortium on Alzheimer’s disease cri-
teria as the currently available standard test to diagnose
MCI [14]. Functional information on daily activities was
collected using Katz Basic Activities of Daily living
(BADL) and Lawton Instrumental Activities of Daily
Living (IADL) questionnaires [15, 16]. The Consortium
criteria include (1) cognitive complaints from the pa-
tients or their families, (2) a decline in cognitive func-
tioning relative to previous abilities during the past
year reported by the patient or informant, (3) cognitive
disorders as evidenced by clinical evaluation (impair-
ment in memory or in another cognitive domain, which
in this study was assessed by MoCA), (4) absence of
major repercussions on daily life (in this study, was
measured by Katz BADL and Lawton IADL), and (5)
absence of dementia (in this study, dementia was ruled
out by using DSM IV criteria [17]). Since depression
can cause cognitive deficits, it was ruled out by using
DSM IV criteria for depression [17].
Statistical analysis
Descriptive statistics was performed on all demographic
and clinical parameters. The prevalence of cognitive im-
pairment was calculated. Baseline patient characteristics
were reported as percentages for categorical variables
and means and standard deviations for continuous ones.
Logistic regression models were constructed to examine
the independent association between peripheral or cen-
tral BP with the MoCA score (normal or abnormal) as
well as the individual cognitive domains (normal or abnor-
mal), and the ECC diagnosis of MCI (present or absent)
separately. All statistical analyses were performed using
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SPSS, with two-sided p-values with statistical significance
set at 0.05.
Ethics approval was obtained from the University of
Alberta Research Ethics Board. Written informed con-
sent was obtained from all the participants in the study.
Results
The average age (± SD) of the subjects was 70 ± 12 years
and the average body mass index was 29 ± 6 kg/m2, with
56% being female, 76% having hypertension, and 42%
being smokers (Table 1). Of the 38 patients on anti-
hypertensive medication, 21% used an ACE-I or ARB
alone, 16% used an ACE-I/ARB and CCB, 13% used an
ACE-I/ARB and beta-blocker, 8% used an ACE-I/ARB
and thiazide diuretic, and 8% used an ACE-I/ARB, CCB,
and thiazide diuretic. The remaining 34% of patients
with hypertension used a variety of other single agents,
or combination of agents.
Fifty-two percent of patients were diagnosed as having
MCI using the ECC. No significant relationship was seen
between any of the measured blood pressure variables
(central or peripheral) and MCI. Mean blood pressures
levels between normal and abnormal clock drawing
and language domains are shown in Table 2. When in-
dividual cognitive domains were analysed with logistic
regression analysis adjusted for age and sex, there was
a significant relationship between the augmentation
index (AI) and clock-drawing completion (OR: 1.08;
95% CI 1.00–1.16, p = 0.04) and language (OR: 1.14;
95% CI: 1.02–1.27; p = 0.02). As shown in Table 3, a
significant relationship was also seen between pulse
pressure amplification and the language sub domain
(OR: 0.36; 95% CI 0.14–0.91; p = 0.03).
Measurements of blood pressure indices were generally
reliable, with good intra-rater reliability indicated by the
intra-class correlation coefficients ranging from 0.92 to
0.97 (Table 4).
Discussion
Hypertension is the most important modifiable risk factor
for the development and progression of cognitive decline.
Cognitive impairment can range from simple memory loss
to deficits in executive function, manifesting as difficulties
with planning and organizing tasks, managing time,
self-care, and decreased processing speed [18]. In the
Canadian Study of Health and Aging (CSHA), executive
function was the earliest-affected cognitive domain and
preceded the development of dementia [19]. CBP may
be more relevant to the study of cognitive impairment
than PBP since the blood is delivered to the brain
through the large central arteries. It has been shown
that in hypertensive subjects, target organ damage is
mediated not only by steady pressure, but also by pulsatile
hemodynamics and blood flow [20]. A systematic review
showed arterial stiffness is associated with cerebral small
vessel disease and decreased cognitive function [21]. In
this study, we analyzed the associations between central
and peripheral blood pressure indices and both global and
domain-specific cognitive function, adjusted for age and
sex. Standard measures of brachial and central BP were
not found to be associated with global cognitive decline or
with individual domains of cognition. In this study, we did
not further adjust for other co-morbidities such as hyper-
tension or diabetes status because these conditions are
causes of arterial stiffness and mediate the co-linear rela-
tionship between blood pressure, arterial stiffness and
outcomes.
The clinical evaluation of arterial stiffness and its pul-
satile hemodynamics is complex. A few studies have
shown a relationship between CBP parameters such as
PP and PWV and indices of cognitive function [22–26].
Among the CBP indices we evaluated in this study, AI
and PPA were found to be significantly associated with
deficits in certain cognitive domains. A lower PPA,
reflecting accelerated arterial aging, was associated with
abnormal language function, and a higher AI was asso-
ciated with both abnormal language and executive func-
tion. Different CBP indices like cfPWV, PPA, and AI may
be measuring different aspects of arterial mechanics, and
there is some evidence that AI may be a better marker for
cardiovascular outcomes. For instance, AI has previously
been shown to distinguish the effects of different BP medi-
cations, when brachial blood pressure and cfPWV were
not able to [27]. Although Mitchell et al. [28] did not find
a relationship between AI and cognitive function, their
study only evaluated adults aged 69 and older, whereas
our study included adults over the age of 50. With pro-
gressive aging, central impedance increases faster than
peripheral impedance and AI can consequently become
Table 1 Baseline demographics
Characteristics Patient Sample (n = 50)
Mean (SD) or No (%)
Age (years): mean (SD) 70 (12)




Past or current smoker 21 (42%)
History of TIA 2 (4%)
History of stroke 5 (10%)
Diabetes 20 (40%)
Type I 1 (2%)
Type II 19 (38%)
MoCA score: mean (SD) 21 (5)
Diagnosed with MCI 26 (52%)
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dissociated from cfPWV and other markers of arterial
stiffness [28]. In addition, with older adults marked
stiffening of the aorta may reduce wave reflection at the
interface between aorta and proximal large arteries,
which result in reduced local and global wave reflec-
tions which may contribute to the dissociation between
measures of aortic stiffness and AI [28].
Tsao et al. in their study showed similar results to our
study in that cfPWV was not associated with cognitive
decline [29]. This lack of association may be attributable
to differences in cognitive tests (MoCA was used in this
study, whereas MMSE was used in other studies). Small
sample size may have reduced the effect size and our
sensitivity to detect association between all blood pressure
indices and cognitive outcomes. Finally, carotid-femoral
pulse wave velocity (cfPWV) seems to mainly measure
arterial stiffness, whereas pulse pressure amplification
(PPA) and Augmentation Index (AI) mainly measures
the hemodynamic wave reflections from the arterial
wall. So these BP indices may be measuring different
aspects of the arterial wall mechanics as well as arterial
flow dynamics and hence the difference seen in this
study.
A strength of this study is its use of the MoCA for
cognitive assessment, which is a more sensitive test for
assessing mild cognitive impairment than the Mini-
Mental State Examination (MMSE), and which also
incorporates an assessment of executive function. We
also employed the standardized Consortium Criteria for
the diagnosis of MCI. To our knowledge, this is the first
Table 2 Mean blood pressure levels in patients with normal and abnormal clock-drawing and language scoresa
Index Clock-Drawing Language
Normal (mean ± SD)
n = 17
Abnormal (mean ± SD)
n = 32
Normal (mean ± SD)
n = 8
Abnormal (mean ± SD)
n = 41
Average brachial systolic blood pressure 142.7 ± 24.8 140.7 ± 18.8 146.2 ± 31.5 140.5 ± 18.5
Average brachial diastolic blood pressure 77.6 ± 13.5 79.3 ± 10.5 84.9 ± 15.7 77.5 ± 10.3
Average brachial pulse pressure 65.1 ± 17.4 61.5 ± 14.4 61.3 ± 18.9 63.0 ± 14.9
Average mean arterial pressure 97.0 ± 16.9 99.2 ± 12.5 103.4 ± 20.7 97.5 ± 12.5
Average central systolic blood pressure 126.2 ± 21.6 127.5 ± 17.3 128.7 ± 27.2 126.8 ± 17.0
Average central diastolic blood pressure 79.1 ± 13.4 80.3 ± 10.3 86.0 ± 15.7 78.7 ± 10.1
Average central pulse pressure 47.1 ± 14.8 47.2 ± 12.5 42.7 ± 14.7 48.0 ± 13.0
Average central augmentation pressure 10.1 ± 8.1 14.4 ± 7.1 7.8 ± 6.9† 13.9 ± 7.5†
Average central augmentation index 18.1 ± 14.1‡ 29.3 ± 9.8‡ 15.3 ± 12.8† 27.4 ± 11.7†
Average pulse pressure amplification 1.4 ± 0.2† 1.3 ± 0.1† 1.5 ± 0.1† 1.3 ± 0.1†
Pulse wave velocity 9.0 ± 2.0 9.3 ± 1.8 9.1 ± 1.5 9.1 ± 2.0
aMann-Whitney U tests were conducted on the blood pressure indices in those with normal vs. abnormal clock-drawing scores, and normal vs. abnormal language
scores. Significant results are noted below
†p < 0.05
‡p < 0.01
Table 3 Association between blood pressure indices and measures of cognitive function-results from logistic regressiona
Index Association with Abnormal Clock-Drawing Association with Abnormal Language Score
Odds ratio (95% CI) p-value Odds ratio (95% CI) p-value
Average brachial systolic blood pressure 0.98 (0.95, 1.02) 0.31 0.93 (0.85, 1.01) 0.08
Average brachial diastolic blood pressure 1.00 (0.95, 1.06) 0.92 0.93 (0.86, 1.01) 0.09
Average brachial pulse pressure 0.96 (0.92, 1.01) 0.14 0.94 (0.87, 1.02) 0.12
Average mean arterial pressure 1.00 (0.95, 1.04) 0.90 0.94 (0.87, 1.02) 0.11
Average central systolic blood pressure 0.99 (0.95, 1.03) 0.55 0.95 (0.89, 1.01) 0.12
Average central diastolic blood pressure 1.00 (0.95, 1.06) 1.00 0.93 (0.85, 1.01) 0.09
Average central pulse pressure 0.97 (0.92, 1.03) 0.37 0.97 (0.88, 1.06) 0.48
Average central augmentation pressure 1.06 (0.95, 1.18) 0.29 1.17 (0.98, 1.41) 0.09
Average central augmentation index 1.08 (1.00, 1.16) 0.04 1.14 (1.02, 1.27) 0.02
Average pulse pressure amplification (for 0.1 unit increase) 0.60 (0.34,1.07) 0.08 0.36 (0.14, 0.91) 0.03
Pulse wave velocity 1.06 (0.72, 1.55) 0.78 0.53 (0.20, 1.41) 0.20
aAdjusted for age and sex
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study to show an association between high AI and
abnormal language and executive function.
Limitations of this study include its cross-sectional
nature, which shows only association and not causation,
and the small sample size. We did not calculate the sam-
ple size. However, we observed significant relationships
between two independent variables (augmentation index
and pulse pressure amplification) and two aspects of
cognition (clock-drawing and language). Although there
was a relationship between these variables and the pri-
mary end-point of the study (presence or absence of
mild cognitive impairment), it did not reach statistical
significance. In addition, as expected augmentation
index (mean ± SD) was higher in those with MCI (MCI
present 26.27 ± 13.81vs MCI absent 23.40 ± 12.28), and
pulse pressure amplification was to be lower in those with
MCI (MCI present 1.34 ± 0.13 vs MCI absent 1.37 ± 0.14)
indicating that our data fit the experimental model.
Conclusion
Results from this study suggests that CBP indices like AI
and PPA, which are markers of vascular stiffness, wave
dynamics and augmentation pressure are associated with
possible poor executive function and language cognitive
domain deficits. These CBP indices may be sensitive
indicators of cognitive decline. Future large studies are
needed to clarify the effect of CBP indices on cognitive
aging.
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